Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.

Kucharczyk K, Rybka JD, Hilgendorff M, Krupinski M, Slachcinski M, Mackiewicz A, Giersig M, Dams-Kozlowska H.

PLoS One. 2019 Jul 15;14(7):e0219790. doi: 10.1371/journal.pone.0219790. eCollection 2019.

2.

NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects.

Papasavvas E, Azzoni L, Kossenkov AV, Dawany N, Morales KH, Fair M, Ross BN, Lynn K, Mackiewicz A, Mounzer K, Tebas P, Jacobson JM, Kostman JR, Showe L, Montaner LJ.

J Immunol. 2019 Jun 28. pii: ji1801511. doi: 10.4049/jimmunol.1801511. [Epub ahead of print]

PMID:
31253727
3.

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor.

Kolenda T, Rutkowski P, Michalak M, Kozak K, Guglas K, Ryś M, Galus Ł, Woźniak S, Ługowska I, Gos A, Teresiak A, Mackiewicz A, Lamperska K, Mackiewicz J.

Oncotarget. 2019 Jun 11;10(39):3879-3893. doi: 10.18632/oncotarget.26989. eCollection 2019 Jun 11.

4.

Pharmacokinetics of a Long-lasting, Highly Concentrated Buprenorphine Solution after Subcutaneous Administration in Rhesus Macaques (Macaca mulatta).

Mackiewicz AL, Salyards GW, Knych HK, Hill AE, Christe KL.

J Am Assoc Lab Anim Sci. 2019 Jul 1;58(4):501-509. doi: 10.30802/AALAS-JAALAS-18-000115. Epub 2019 Jun 21.

PMID:
31227029
5.

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

Robert C, Grob JJ, Stroyakovskiy D, Karaszewska B, Hauschild A, Levchenko E, Chiarion Sileni V, Schachter J, Garbe C, Bondarenko I, Gogas H, Mandalá M, Haanen JBAG, Lebbé C, Mackiewicz A, Rutkowski P, Nathan PD, Ribas A, Davies MA, Flaherty KT, Burgess P, Tan M, Gasal E, Voi M, Schadendorf D, Long GV.

N Engl J Med. 2019 Jun 4. doi: 10.1056/NEJMoa1904059. [Epub ahead of print]

PMID:
31166680
6.

Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.

Kolenda T, Guglas K, Kopczyńska M, Teresiak A, Bliźniak R, Mackiewicz A, Lamperska K, Mackiewicz J.

Cells. 2019 Apr 21;8(4). pii: E366. doi: 10.3390/cells8040366.

7.

Natural T cell autoreactivity to melanoma antigens: clonally expanded melanoma-antigen specific CD8 + memory T cells can be detected in healthy humans.

Przybyla A, Zhang T, Li R, Roen DR, Mackiewicz A, Lehmann PV.

Cancer Immunol Immunother. 2019 May;68(5):709-720. doi: 10.1007/s00262-018-02292-7. Epub 2019 Feb 19.

PMID:
30783693
8.

I like to go out and have a good time: An ethnography of a group of young middle class urban Indian women participating in a new drinking culture.

Murdeshwar S, Riley S, Mackiewicz A.

Int J Drug Policy. 2019 Apr;66:1-8. doi: 10.1016/j.drugpo.2019.01.003. Epub 2019 Jan 19.

PMID:
30669000
9.
10.

The expression signature of cancer-associated KRAB-ZNF factors identified in TCGA pan-cancer transcriptomic data.

Machnik M, Cylwa R, Kiełczewski K, Biecek P, Liloglou T, Mackiewicz A, Oleksiewicz U.

Mol Oncol. 2019 Apr;13(4):701-724. doi: 10.1002/1878-0261.12407. Epub 2019 Feb 16.

11.

lncRNA Expression after Irradiation and Chemoexposure of HNSCC Cell Lines.

Guglas K, Kolenda T, Teresiak A, Kopczyńska M, Łasińska I, Mackiewicz J, Mackiewicz A, Lamperska K.

Noncoding RNA. 2018 Nov 14;4(4). pii: E33. doi: 10.3390/ncrna4040033.

12.

Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients.

Kwiatkowska-Borowczyk E, Czerwińska P, Mackiewicz J, Gryska K, Kazimierczak U, Tomela K, Przybyła A, Kozłowska AK, Galus Ł, Kwinta Ł, Dondajewska E, Gąbka-Buszek A, Żakowska M, Mackiewicz A.

Oncoimmunology. 2018 Aug 24;7(11):e1509821. doi: 10.1080/2162402X.2018.1509821. eCollection 2018.

13.

Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women.

Papasavvas E, Kossenkov AV, Azzoni L, Zetola NM, Mackiewicz A, Ross BN, Fair M, Vadrevu S, Ramogola-Masire D, Sanne I, Firnhaber C, Montaner LJ.

Carcinogenesis. 2019 Apr 29;40(2):225-233. doi: 10.1093/carcin/bgy149.

PMID:
30364933
14.

Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics.

Florczak A, Jastrzebska K, Bialas W, Mackiewicz A, Dams-Kozlowska H.

J Biomed Mater Res A. 2018 Dec;106(12):3211-3221. doi: 10.1002/jbm.a.36516. Epub 2018 Sep 22.

PMID:
30242958
15.

Bioengineering the spider silk sequence to modify its affinity for drugs.

Kucharczyk K, Weiss M, Jastrzebska K, Luczak M, Ptak A, Kozak M, Mackiewicz A, Dams-Kozlowska H.

Int J Nanomedicine. 2018 Jul 20;13:4247-4261. doi: 10.2147/IJN.S168081. eCollection 2018.

16.

BRAF and MEK inhibitors in the era of immunotherapy in melanoma patients.

Mackiewicz J, Mackiewicz A.

Contemp Oncol (Pozn). 2018 Mar;22(1A):68-72. doi: 10.5114/wo.2018.73890. Epub 2018 Mar 5. Review.

17.

Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population.

Mackiewicz-Wysocka M, Czerwińska P, Filas V, Bogajewska E, Kubicka A, Przybyła A, Dondajewska E, Kolenda T, Marszałek A, Mackiewicz A.

Postepy Dermatol Alergol. 2017 Oct;34(5):490-498. doi: 10.5114/ada.2017.71119. Epub 2017 Oct 31.

18.

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Maio M, Lewis K, Demidov L, Mandalà M, Bondarenko I, Ascierto PA, Herbert C, Mackiewicz A, Rutkowski P, Guminski A, Goodman GR, Simmons B, Ye C, Yan Y, Schadendorf D; BRIM8 Investigators.

Lancet Oncol. 2018 Apr;19(4):510-520. doi: 10.1016/S1470-2045(18)30106-2. Epub 2018 Feb 21. Erratum in: Lancet Oncol. 2018 Apr;19(4):e184.

PMID:
29477665
19.

Heterotypic breast cancer model based on a silk fibroin scaffold to study the tumor microenvironment.

Dondajewska E, Juzwa W, Mackiewicz A, Dams-Kozlowska H.

Oncotarget. 2017 Dec 22;9(4):4935-4950. doi: 10.18632/oncotarget.23574. eCollection 2018 Jan 12.

20.

Delivery of chemotherapeutics using spheres made of bioengineered spider silks derived from MaSp1 and MaSp2 proteins.

Jastrzebska K, Florczak A, Kucharczyk K, Lin Y, Wang Q, Mackiewicz A, Kaplan DL, Dams-Kozlowska H.

Nanomedicine (Lond). 2018 Feb;13(4):439-454. doi: 10.2217/nnm-2017-0276. Epub 2018 Jan 17.

21.

Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment.

Zaleska K, Przybyła A, Kulcenty K, Wichtowski M, Mackiewicz A, Suchorska W, Murawa D.

Oncol Lett. 2017 Oct;14(4):4029-4036. doi: 10.3892/ol.2017.6718. Epub 2017 Aug 3.

22.

TRIM28 epigenetic corepressor is indispensable for stable induced pluripotent stem cell formation.

Klimczak M, Czerwińska P, Mazurek S, Sozańska B, Biecek P, Mackiewicz A, Wiznerowicz M.

Stem Cell Res. 2017 Aug;23:163-172. doi: 10.1016/j.scr.2017.07.012. Epub 2017 Jul 15.

23.

Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.

Kozlowska AK, Florczak A, Smialek M, Dondajewska E, Mackiewicz A, Kortylewski M, Dams-Kozlowska H.

Acta Biomater. 2017 Sep 1;59:221-233. doi: 10.1016/j.actbio.2017.07.014. Epub 2017 Jul 8.

24.

Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials.

Schadendorf D, Long GV, Stroiakovski D, Karaszewska B, Hauschild A, Levchenko E, Chiarion-Sileni V, Schachter J, Garbe C, Dutriaux C, Gogas H, Mandalà M, Haanen JBAG, Lebbé C, Mackiewicz A, Rutkowski P, Grob JJ, Nathan P, Ribas A, Davies MA, Zhang Y, Kaper M, Mookerjee B, Legos JJ, Flaherty KT, Robert C.

Eur J Cancer. 2017 Sep;82:45-55. doi: 10.1016/j.ejca.2017.05.033. Epub 2017 Jun 22.

PMID:
28648698
25.

Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma.

Mackiewicz J, Mackiewicz A.

Contemp Oncol (Pozn). 2017;21(1):1-5. doi: 10.5114/wo.2017.66651. Epub 2017 Mar 22. Review.

26.

HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.

Papasavvas E, Azzoni L, Yin X, Liu Q, Joseph J, Mackiewicz A, Ross B, Lynn KM, Jacobson JM, Mounzer K, Kostman JR, Montaner LJ.

J Viral Hepat. 2017 Oct;24(10):865-876. doi: 10.1111/jvh.12714. Epub 2017 May 11.

27.

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial.

Ascierto PA, Del Vecchio M, Robert C, Mackiewicz A, Chiarion-Sileni V, Arance A, Lebbé C, Bastholt L, Hamid O, Rutkowski P, McNeil C, Garbe C, Loquai C, Dreno B, Thomas L, Grob JJ, Liszkay G, Nyakas M, Gutzmer R, Pikiel J, Grange F, Hoeller C, Ferraresi V, Smylie M, Schadendorf D, Mortier L, Svane IM, Hennicken D, Qureshi A, Maio M.

Lancet Oncol. 2017 May;18(5):611-622. doi: 10.1016/S1470-2045(17)30231-0. Epub 2017 Mar 27.

PMID:
28359784
28.

Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer.

Huzarski T, Górecka-Szyld B, Huzarska J, Psut-Muszyńska G, Wilk G, Sibilski R, Cybulski C, Kozak-Klonowska B, Siołek M, Kilar E, Czudowska D, Janiszewska H, Godlewski D, Mackiewicz A, Jarkiewicz-Tretyn J, Szabo-Moskal J, Gronwald J, Lubiński J, Narod SA; Polish Hereditary Breast Cancer Study Group.

Hered Cancer Clin Pract. 2017 Mar 1;15:4. doi: 10.1186/s13053-017-0064-y. eCollection 2017.

29.

TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.

Czerwińska P, Shah PK, Tomczak K, Klimczak M, Mazurek S, Sozańska B, Biecek P, Korski K, Filas V, Mackiewicz A, Andersen JN, Wiznerowicz M.

Oncotarget. 2017 Jan 3;8(1):863-882. doi: 10.18632/oncotarget.13273.

30.

The method of purifying bioengineered spider silk determines the silk sphere properties.

Jastrzebska K, Felcyn E, Kozak M, Szybowicz M, Buchwald T, Pietralik Z, Jesionowski T, Mackiewicz A, Dams-Kozlowska H.

Sci Rep. 2016 Jun 17;6:28106. doi: 10.1038/srep28106.

31.

Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed Mice.

Dams-Kozlowska H, Kwiatkowska-Borowczyk E, Gryska K, Lewandowska A, Marszalek A, Adamczyk S, Kowalik A, Leporowska E, Mackiewicz A.

PLoS One. 2016 May 4;11(5):e0154520. doi: 10.1371/journal.pone.0154520. eCollection 2016.

32.

Comparative studies of cervical spine anterior stabilization systems--Finite element analysis.

Mackiewicz A, Banach M, Denisiewicz A, Bedzinski R.

Clin Biomech (Bristol, Avon). 2016 Feb;32:72-9. doi: 10.1016/j.clinbiomech.2015.11.016. Epub 2015 Dec 5.

PMID:
26851563
33.

Analysis of sequence variants in the 3'UTR of CDKN2A gene in melanoma patients.

Przybyła A, Lamperska K, Mackiewicz A.

Contemp Oncol (Pozn). 2015;19(4):276-9. doi: 10.5114/wo.2015.54227. Epub 2015 Sep 28.

34.

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.

Grob JJ, Amonkar MM, Karaszewska B, Schachter J, Dummer R, Mackiewicz A, Stroyakovskiy D, Drucis K, Grange F, Chiarion-Sileni V, Rutkowski P, Lichinitser M, Levchenko E, Wolter P, Hauschild A, Long GV, Nathan P, Ribas A, Flaherty K, Sun P, Legos JJ, McDowell DO, Mookerjee B, Schadendorf D, Robert C.

Lancet Oncol. 2015 Oct;16(13):1389-98. doi: 10.1016/S1470-2045(15)00087-X.

PMID:
26433819
35.

Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model.

Mackiewicz J, Kazimierczak U, Kotlarski M, Dondajewska E, Kozłowska A, Kwiatkowska E, Nowicka-Kotlarska A, Dams-Kozłowska H, Wysocki PJ, Mackiewicz A.

Anticancer Res. 2015 Jun;35(6):3275-88.

PMID:
26026087
36.

Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma.

Mackiewicz J, Karczewska-Dzionk A, Laciak M, Kapcinska M, Wiznerowicz M, Burzykowski T, Zakowska M, Rose-John S, Mackiewicz A.

Medicine (Baltimore). 2015 May;94(21):e853. doi: 10.1097/MD.0000000000000853. Erratum in: Medicine (Baltimore). 2015 Jun;94(25):1.

37.

Silk as an innovative biomaterial for cancer therapy.

Jastrzebska K, Kucharczyk K, Florczak A, Dondajewska E, Mackiewicz A, Dams-Kozlowska H.

Rep Pract Oncol Radiother. 2014 Dec 18;20(2):87-98. doi: 10.1016/j.rpor.2014.11.010. eCollection 2015 Mar-Apr. Review.

38.

Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, Desbois M, Jacquelot N, Vimond N, Chouaib S, Mateus C, Allison JP, Ribas A, Wolchok JD, Yuan J, Wong P, Postow M, Mackiewicz A, Mackiewicz J, Schadendorff D, Jaeger D, Korman AJ, Bahjat K, Maio M, Calabro L, Teng MW, Smyth MJ, Eggermont A, Robert C, Kroemer G, Zitvogel L.

Cell Res. 2015 Mar;25(3):399-400. doi: 10.1038/cr.2015.28. No abstract available.

39.

Immunotargeting of cancer stem cells.

Kwiatkowska-Borowczyk EP, Gąbka-Buszek A, Jankowski J, Mackiewicz A.

Contemp Oncol (Pozn). 2015;19(1A):A52-9. doi: 10.5114/wo.2014.47129. Review.

40.

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, Desbois M, Jacquelot N, Vimond N, Chouaib S, Mateus C, Allison JP, Ribas A, Wolchok JD, Yuan J, Wong P, Postow M, Mackiewicz A, Mackiewicz J, Schadendorff D, Jaeger D, Zörnig I, Hassel J, Korman AJ, Bahjat K, Maio M, Calabro L, Teng MW, Smyth MJ, Eggermont A, Robert C, Kroemer G, Zitvogel L.

Cell Res. 2015 Feb;25(2):208-24. doi: 10.1038/cr.2015.3. Epub 2015 Jan 13. Erratum in: Cell Res. 2015 Mar;25(3):399-400. Zörnig, Inka [added]; Hassel, Jessica [added].

41.

The mystery of let-7d - a small RNA with great power.

Kolenda T, Przybyła W, Teresiak A, Mackiewicz A, Lamperska KM.

Contemp Oncol (Pozn). 2014;18(5):293-301. doi: 10.5114/wo.2014.44467. Epub 2014 Nov 5. Review.

42.

The anti-cancer actions of O6-methylguanine-DNA-methyltransferase in relation to colon polyps.

Kycler W, Korski K, Loziński C, Teresiak-Mańczak A, Przybyła A, Mackiewicz A, Cybulski Z, Lamperska K.

Pharmacol Rep. 2014 Dec;66(6):1060-4. doi: 10.1016/j.pharep.2014.06.019. Epub 2014 Jul 8.

PMID:
25443735
43.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Robert C, Karaszewska B, Schachter J, Rutkowski P, Mackiewicz A, Stroiakovski D, Lichinitser M, Dummer R, Grange F, Mortier L, Chiarion-Sileni V, Drucis K, Krajsova I, Hauschild A, Lorigan P, Wolter P, Long GV, Flaherty K, Nathan P, Ribas A, Martin AM, Sun P, Crist W, Legos J, Rubin SD, Little SM, Schadendorf D.

N Engl J Med. 2015 Jan 1;372(1):30-9. doi: 10.1056/NEJMoa1412690. Epub 2014 Nov 16.

44.

Functionalized spider silk spheres as drug carriers for targeted cancer therapy.

Florczak A, Mackiewicz A, Dams-Kozlowska H.

Biomacromolecules. 2014 Aug 11;15(8):2971-81. doi: 10.1021/bm500591p. Epub 2014 Jul 7.

PMID:
24963985
45.

Designer cytokine hyper interleukin 11 (H11) is a megakaryopoietic factor.

Dams-Kozlowska H, Kwiatkowska-Borowczyk E, Gryska K, Mackiewicz A.

Int J Med Sci. 2013 Jul 9;10(9):1157-65. doi: 10.7150/ijms.5638. Print 2013.

46.

Development of a new, simple and cost-effective diagnostic tool for genetic screening of hereditary colorectal cancer--the DNA microarray assay.

Stojcev Z, Banasiewicz T, Kaszuba M, Sikorski A, Szczepkowski M, Bobkiewicz A, Paszkowski J, Krokowicz Ł, Biczysko M, Szmeja J, Jurkowska M, Majewski P, Mackiewicz A, Lamperska K, Drews M, Wojciechowicz J.

Acta Biochim Pol. 2013;60(2):195-8. Epub 2013 Jun 6.

47.

Therapeutic gene modified cell based cancer vaccines.

Kozłowska A, Mackiewicz J, Mackiewicz A.

Gene. 2013 Aug 10;525(2):200-7. doi: 10.1016/j.gene.2013.03.056. Epub 2013 Apr 6. Review.

PMID:
23566846
48.

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis.

Wiater K, Switaj T, Mackiewicz J, Kalinka-Warzocha E, Wojtukiewicz M, Szambora P, Falkowski S, Rogowski W, Mackiewicz A, Rutkowski P.

Contemp Oncol (Pozn). 2013;17(3):257-62. doi: 10.5114/wo.2013.35785. Epub 2013 Jun 28.

49.

Purification and cytotoxicity of tag-free bioengineered spider silk proteins.

Dams-Kozlowska H, Majer A, Tomasiewicz P, Lozinska J, Kaplan DL, Mackiewicz A.

J Biomed Mater Res A. 2013 Feb;101(2):456-64. doi: 10.1002/jbm.a.34353. Epub 2012 Aug 3.

50.

Electrostatic interactions of monoclonal antibodies with subcutaneous tissue.

Mach H, Gregory SM, Mackiewicz A, Mittal S, Lalloo A, Kirchmeier M, Shameem M.

Ther Deliv. 2011 Jun;2(6):727-36.

PMID:
22822505

Supplemental Content

Loading ...
Support Center